(VIANEWS) - Cabot Oil & Gas Corporation (COG), Molina Healthcare (MOH), Kadant (KAI) are the highest sales growth and return on equity stocks on this list.
Here is a list of stocks with an above 5% expected next quarter sales growth, and a 3% or higher return on equity. May these stocks be a good medium-term investment option?
1. Cabot Oil & Gas Corporation (COG)
150.9% sales growth and 12.23% return on equity
Cabot Oil & Gas Corporation, an independent oil and gas company, explores for, exploits, develops, produces, and markets oil and gas properties in the United States.
Cabot Oil & Gas Corporation's sales growth this year is expected to be 68.2% and 100.2% for next year.
Year-on-year quarterly revenue growth grew by 42.8%, now sitting on 1.63B for the twelve trailing months.
Volume
Today's last reported volume for Cabot Oil & Gas Corporation is 18763900 which is 62.19% above its average volume of 11568600.
Cabot Oil & Gas Corporation's sales growth is a negative 0% for the current quarter and 150.9% for the next. The company's growth estimates for the current quarter and the next is 388.9% and 134.6%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 12.23%.
Volatility
Cabot Oil & Gas Corporation's last day, last week, and last month's current volatility was 0.37%, 1.27%, and 1.86%, respectively.
Cabot Oil & Gas Corporation's current volatility rank, which measures how volatile a financial asset is (variation between the lowest and highest value in a period), was 2.23% (day), 4.42% (last week), and 3.76% (last month), respectively.
Cabot Oil & Gas Corporation's Stock Yearly Top and Bottom Value
Cabot Oil & Gas Corporation's stock is valued at $22.25 at 10:22 EST, under its 52-week high of $23.64 and way above its 52-week low of $14.28.
Cabot Oil & Gas Corporation's Moving Average
Cabot Oil & Gas Corporation's value is way higher than its 50-day moving average of $19.87 and way higher than its 200-day moving average of $17.47.2. Molina Healthcare (MOH)
25.7% sales growth and 28.95% return on equity
Molina Healthcare, Inc. provides managed health care services to low-income families and individuals under the Medicaid and Medicare programs and through the state insurance marketplaces.
Molina Healthcare's sales growth this year is anticipated to be 35.6% and 7.1% for next year.
Year-on-year quarterly revenue growth grew by 50.7%, now sitting on 22.6B for the twelve trailing months.
Volume
Today's last reported volume for Molina Healthcare is 134003 which is 47.05% below its average volume of 253118.
Molina Healthcare's sales growth is a negative 0% for the ongoing quarter and 25.7% for the next. The company's growth estimates for the ongoing quarter and the next is a negative 14.3% and 629.4%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 28.95%.
Volatility
Molina Healthcare's last day, last week, and last month's current volatility was 0.28%, 1.08%, and 1.08%, respectively.
Molina Healthcare's current volatility rank, which measures how volatile a financial asset is (variation between the lowest and highest value in a period), was 1.63% (day), 3.05% (last week), and 2.56% (last month), respectively.
Molina Healthcare's Stock Yearly Top and Bottom Value
Molina Healthcare's stock is valued at $305.38 at 10:22 EST, below its 52-week high of $312.52 and way above its 52-week low of $196.08.
Molina Healthcare's Moving Average
Molina Healthcare's worth is higher than its 50-day moving average of $285.70 and way higher than its 200-day moving average of $265.12.3. Kadant (KAI)
25% sales growth and 15.29% return on equity
Kadant Inc. supplies equipment and critical components worldwide.
Kadant's sales growth this year is anticipated to be 23.1% and 13.1% for next year.
Year-on-year quarterly revenue growth grew by 29.2%, now sitting on 736.49M for the twelve trailing months.
Volume
Today's last reported volume for Kadant is 5513 which is 82.4% below its average volume of 31326.
Kadant's sales growth for the next quarter is 25%. The company's growth estimates for the current quarter and the next is 32.5% and 34%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 15.29%.
Volatility
Kadant's last day, last week, and last month's current volatility was 1.46%, 1.41%, and 1.19%, respectively.
Kadant's current volatility rank, which measures how volatile a financial asset is (variation between the lowest and highest value in a period), was 3.30% (day), 5.34% (last week), and 2.85% (last month), respectively.
Kadant's Stock Yearly Top and Bottom Value
Kadant's stock is valued at $229.41 at 10:22 EST, below its 52-week high of $236.60 and way higher than its 52-week low of $124.91.
Kadant's Moving Average
Kadant's worth is higher than its 50-day moving average of $214.01 and way above its 200-day moving average of $192.35.4. Edwards Lifesciences (EW)
18.2% sales growth and 32.6% return on equity
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States and internationally.
Edwards Lifesciences's sales growth this year is anticipated to be 21.4% and 11.1% for next year.
Year-on-year quarterly revenue growth grew by 48.8%, now sitting on 4.93B for the twelve trailing months.
Volume
Today's last reported volume for Edwards Lifesciences is 98398 which is 95.33% below its average volume of 2108850.
Edwards Lifesciences's sales growth for the next quarter is 18.2%. The company's growth estimates for the current quarter and the next is 5.9% and 12%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 32.6%.
Volatility
Edwards Lifesciences's last day, last week, and last month's current volatility was 3.90%, 1.45%, and 1.24%, respectively.
Edwards Lifesciences's current volatility rank, which measures how volatile a financial asset is (variation between the lowest and highest value in a period), was 4.49% (day), 2.24% (last week), and 2.40% (last month), respectively.
Edwards Lifesciences's Stock Yearly Top and Bottom Value
Edwards Lifesciences's stock is valued at $115.13 at 10:22 EST, under its 52-week high of $123.27 and way above its 52-week low of $78.34.
Edwards Lifesciences's Moving Average
Edwards Lifesciences's value is higher than its 50-day moving average of $114.72 and higher than its 200-day moving average of $108.17.Previous days news about Edwards Lifesciences(EW)
- Notable edwards lifesciences insider trades $4.9m in company stock. According to Benzinga on Wednesday, 10 November, "What Happened: A Form 4 filing from the U.S. Securities and Exchange Commission states that Michael Mussallem exercised options to purchase 57,550 Edwards Lifesciences shares at prices ranging from ($0.00) to $21.76 per share for a total of $980,288 on November 9. ", "Following the transaction, Mussallem still owns 3,594,507 shares of Edwards Lifesciences worth $430,010,872."
5. ConnectOne Bancorp (CNOB)
12.6% sales growth and 12.36% return on equity
ConnectOne Bancorp, Inc. operates as the bank holding company for ConnectOne Bank, a chartered commercial bank that provides various commercial banking products and services.
ConnectOne Bancorp's sales growth this year is anticipated to be 11.4% and 6.6% for next year.
Year-on-year quarterly revenue growth grew by 20.5%, now sitting on 270.46M for the twelve trailing months.
Volume
Today's last reported volume for ConnectOne Bancorp is 104953 which is 20.05% below its average volume of 131275.
ConnectOne Bancorp's sales growth for the next quarter is 12.6%. The company's growth estimates for the current quarter and the next is 16.9% and negative -11%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 12.36%.
ConnectOne Bancorp's Stock Yearly Top and Bottom Value
ConnectOne Bancorp's stock is valued at $34.74 at 10:22 EST, below its 52-week high of $35.22 and way above its 52-week low of $16.63.
ConnectOne Bancorp's Moving Average
ConnectOne Bancorp's value is above its 50-day moving average of $32.17 and way above its 200-day moving average of $28.61.6. Rollins (ROL)
9.2% sales growth and 34.88% return on equity
Rollins, Inc., through its subsidiaries, provides pest and termite control services to residential and commercial customers.
Rollins's sales growth this year is anticipated to be 11.3% and 6.8% for next year.
Year-on-year quarterly revenue growth grew by 15.3%, now sitting on 2.29B for the twelve trailing months.
Volume
Today's last reported volume for Rollins is 17394 which is 98.5% below its average volume of 1164840.
Rollins's sales growth for the next quarter is 9.2%. The company's growth estimates for the current quarter and the next is 17.6% and 15.4%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 34.88%.
Volatility
Rollins's last day, last week, and last month's current volatility was 0.87%, 1.31%, and 1.67%, respectively.
Rollins's current volatility rank, which measures how volatile a financial asset is (variation between the lowest and highest value in a period), was 1.39% (day), 2.17% (last week), and 2.51% (last month), respectively.
Rollins's Stock Yearly Top and Bottom Value
Rollins's stock is valued at $35.88 at 10:22 EST, way under its 52-week high of $41.83 and way above its 52-week low of $31.44.
Rollins's Moving Average
Rollins's value is under its 50-day moving average of $36.56 and under its 200-day moving average of $36.37.7. F5 Networks (FFIV)
7% sales growth and 13.9% return on equity
F5 Networks, Inc. provides multi-cloud application services for the security, performance, and availability of network applications, servers, and storage systems.
F5 Networks's sales growth this year is anticipated to be 10% and 7% for next year.
Year-on-year quarterly revenue growth grew by 10.6%, now sitting on 2.47B for the twelve trailing months.
Volume
Today's last reported volume for F5 Networks is 502942 which is 25.89% above its average volume of 399496.
F5 Networks's sales growth for the next quarter is 7%. The company's growth estimates for the current quarter and the next is 13.2% and 6.6%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 13.9%.
Volatility
F5 Networks's last day, last week, and last month's current volatility was 0.04%, 0.50%, and 1.31%, respectively.
F5 Networks's current volatility rank, which measures how volatile a financial asset is (variation between the lowest and highest value in a period), was 2.36% (day), 2.24% (last week), and 2.59% (last month), respectively.
F5 Networks's Stock Yearly Top and Bottom Value
F5 Networks's stock is valued at $225.46 at 10:22 EST, under its 52-week high of $229.23 and way higher than its 52-week low of $155.33.
F5 Networks's Moving Average
F5 Networks's worth is higher than its 50-day moving average of $207.77 and way higher than its 200-day moving average of $197.29.8. Casa Systems (CASA)
6% sales growth and 48.04% return on equity
Casa Systems, Inc., a communications technology company, provides solutions for next-generation centralized, distributed, and virtualized architectures for cable broadband, fixed-line broadband, and wireless networks in North America, Latin America, the Asia-Pacific, Europe, the Middle East, and Africa.
Casa Systems's sales growth this year is expected to be 10.3% and 10.1% for next year.
Year-on-year quarterly revenue growth grew by 11.3%, now sitting on 423.28M for the twelve trailing months.
Volume
Today's last reported volume for Casa Systems is 329868 which is 33.8% above its average volume of 246528.
Casa Systems's sales growth for the next quarter is 6%. The company's growth estimates for the current quarter and the next is a negative 28.6% and negative -55.6%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 48.04%.
Volatility
Casa Systems's last day, last week, and last month's current volatility was 1.93%, 4.57%, and 2.45%, respectively.
Casa Systems's current volatility rank, which measures how volatile a financial asset is (variation between the lowest and highest value in a period), was 6.51% (day), 8.21% (last week), and 4.70% (last month), respectively.
Casa Systems's Stock Yearly Top and Bottom Value
Casa Systems's stock is valued at $5.70 at 10:22 EST, way under its 52-week high of $13.15 and way higher than its 52-week low of $4.39.